Cargando…

The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression

BACKGROUND: Given the fact that prostate cancer incidence will increase in the coming years, new prognostic biomarkers are needed with regard to the biological aggressiveness of the prostate cancer diagnosed. Since cytokines have been associated with the biology of cancer and its prognosis, we deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schroten, Caroline, Dits, Natasja F., Steyerberg, Ewout W., Kranse, Ries, van Leenders, Arno G. J. L. H., Bangma, Chris H., Kraaij, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362718/ https://www.ncbi.nlm.nih.gov/pubmed/22113713 http://dx.doi.org/10.1007/s00262-011-1159-3

Ejemplares similares

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015)

C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer
por: Martens-Uzunova, Elena S., et al.
Publicado: (2015)

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases
por: Böttcher, René, et al.
Publicado: (2016)

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2015)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens
por: Hollemans, Eva, et al.
Publicado: (2019)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Prostate cancer screening in Europe and Asia
por: Zhang, Kai, et al.
Publicado: (2017)

Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models
por: Marques, Rute B., et al.
Publicado: (2010)

Men's preferences for prostate cancer screening: a discrete choice experiment
por: de Bekker-Grob, E W, et al.
Publicado: (2013)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

The future of prostate cancer research: bringing data together, looking back and forward
por: Bangma, Chris, et al.
Publicado: (2018)

Overdiagnosis and overtreatment of early detected prostate cancer
por: Bangma, C. H., et al.
Publicado: (2007)

Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines
por: Marques, Rute B., et al.
Publicado: (2011)

Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens
por: Rijstenberg, L. Lucia, et al.
Publicado: (2020)

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease
por: Schoots, Ivo G., et al.
Publicado: (2018)

Personalized schedules for surveillance of low‐risk prostate cancer patients
por: Tomer, Anirudh, et al.
Publicado: (2018)

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
por: Verbeek, Jan F.M., et al.
Publicado: (2019)

Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment
por: de Bekker-Grob, E W, et al.
Publicado: (2013)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2019)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2009)

Clinical prediction models : a practical approach to development, validation, and updating /
por: Steyerberg, Ewout W.
Publicado: (2009)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
por: Hansum, Tim, et al.
Publicado: (2021)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2018)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer
por: Moll, Jan Matthijs, et al.
Publicado: (2022)

Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer
por: van den Bergh, Roderick C. N., et al.
Publicado: (2009)

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
por: Rodríguez-Blanco, Giovanny, et al.
Publicado: (2018)

Mining the contribution of intensive care clinical course to outcome after traumatic brain injury
por: Bhattacharyay, Shubhayu, et al.
Publicado: (2023)

Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35
por: Bayrak Degirmenci, P., et al.
Publicado: (2018)

Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models
por: Austin, Peter C, et al.
Publicado: (2013)

Monitoring prognosis in severe traumatic brain injury
por: Maas, Andrew IR, et al.
Publicado: (2014)

Interpreting the concordance statistic of a logistic regression model: relation to the variance and odds ratio of a continuous explanatory variable
por: Austin, Peter C, et al.
Publicado: (2012)

Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers
por: Austin, Peter C., et al.
Publicado: (2013)

Methods for individualized assessment of absolute risk in case-control studies should be weighted carefully
por: Haaf, Kevin Ten, et al.
Publicado: (2016)

Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models
por: Austin, Peter C, et al.
Publicado: (2014)

Praise to Robust Prediction Modeling in Large Datasets
por: Steyerberg, Ewout W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dajgmomnp3icuaf6ra3a2v7eas